Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors
Xilio Therapeutics, a clinical-stage biotech company focused on developing masked immuno-oncology therapies, announced the appointment of Cheryl R. Blanchard, Ph.D., a seasoned leader in life sciences, to its board of directors. Dr. Blanchard’s extensive experience in biologics, small molecules, and medical devices will support Xilio's advancement …